Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1716.00 | 1551.25 | 1.1062 | 1.1593 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 622.75 | 569.00 | 1551.25 | 0.3668 | -0.0663 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1517.00 | 1551.25 | 0.9779 | 0.9664 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1410.00 | 1551.25 | 0.9089 | 0.8601 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 622.75 | 1571.00 | 1551.25 | 1.0127 | 1.0193 |
| BT-20 | Lapatinib | 1 | uM | 8 | 1250.00 | 622.75 | 1543.00 | 1551.25 | 0.9947 | 0.9919 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1308.00 | 1551.25 | 0.8432 | 0.7570 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1225.00 | 1551.25 | 0.7897 | 0.6717 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3172.00 | 3809.50 | 0.8327 | 0.7705 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3672.00 | 3809.50 | 0.9639 | 0.9517 | |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 3426.00 | 3809.50 | 0.8993 | 0.8636 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 2937.00 | 3809.50 | 0.7710 | 0.6821 |
| BT-20 | Linsitinib | 10 | uM | 8 | 2500.00 | 1344.63 | 2970.00 | 3809.50 | 0.7796 | 0.6946 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 4038.00 | 3809.50 | 1.0600 | 1.0791 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1344.63 | 2439.00 | 3809.50 | 0.6402 | 0.4864 |
| BT-20 | Erlotinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3311.00 | 3809.50 | 0.8691 | 0.8218 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 2500.00 | 1344.63 | 4114.00 | 3809.50 | 1.0799 | 1.1050 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4123.00 | 3809.50 | 1.0823 | 1.1081 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3699.00 | 3809.50 | 0.9710 | 0.9612 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 4196.00 | 3809.50 | 1.1015 | 1.1329 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 4313.00 | 3809.50 | 1.1322 | 1.1723 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 2500.00 | 1344.63 | 4342.00 | 3809.50 | 1.1398 | 1.1820 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4170.00 | 3809.50 | 1.0946 | 1.1241 | |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1344.63 | 3919.00 | 3809.50 | 1.0287 | 1.0381 |
| BT-20 | Erlotinib | 10 | uM | 8 | 2500.00 | 1344.63 | 2818.00 | 3809.50 | 0.7397 | 0.6364 |